Morgan State University was chosen to create custom biopharma educational programming and increase recruitment of Black talent in the biopharma industry.
Tagged with: biopharmaceutical hbcu higher education Morgan State
Read More »August 13, 2021 Comments Off on Morgan State to launch push for HBCU talent in biopharma industry
Morgan State University was chosen to create custom biopharma educational programming and increase recruitment of Black talent in the biopharma industry.
Tagged with: biopharmaceutical hbcu higher education Morgan State
Read More »July 29, 2021 Comments Off on I-Mab OKs renewed stock repurchase program for up to $40M
I-Mab, a Chinese biopharmaceutical company with U.S. offices in Rockville, announced its board of directors has authorized a new stock repurchase program.
Tagged with: biopharmaceutical
Read More »January 14, 2019 Comments Off on UK drug company to put US headquarters in Rockville, create 170 jobs
Autolus, a biopharmaceutical company based in the United Kingdom, plans to create a new U.S. headquarters in Rockville, creating about 170 jobs by 2021. The company discovers and develops cancer treatments using T-cell programming and manufacturing. “Autolus is delighted to ...
Tagged with: Autolus biopharmaceutical
Read More »January 2, 2018 Comments Off on NexImmune finishes $23 million Series A round
A Gaithersburg biopharmaceutical company has raised $23 million in Series A financing, the company announced Tuesday. NexImmune raised the money in a round co-led by ArrowMark Partners and Barer & Son, along with participation from Piedmont Capital Partners. ArrowMark is ...
Tagged with: biopharmaceutical funding NexImmune series A
Read More »June 26, 2017 Comments Off on Md. lures Vitreon to Baltimore; firm plans to create 200 jobs
Medicinal botanical company Vitreon America announced Monday it plans to move its corporate headquarters to Baltimore from Virginia, creating 200 full-time jobs over the next five years. In addition to its new headquarters on Wicomico Street, the company also indicated it ...
Tagged with: biopharmaceutical morgan state university tax credits Vitreon
Read More »May 20, 2014 Comments Off on GlycoMimetics-Pfizer accord pays off
GlycoMimetics Inc., of Gaithersburg, a biopharmaceutical company focused on discovering and developing drugs for human wound healing and tissue repair, said it has received a $15 million payment from Pfizer Inc., under a collaborative agreement between the two companies for the development of rivipansel, a treatment for painful episodic flare-ups of sickle cell disease.
Tagged with: biopharmaceutical maryland medicine
Read More »August 22, 2013 Comments Off on Study: Ebola treatment shows promise
FREDERICK — A new study authored by Army scientists at Fort Detrick reports that a treatment grown in tobacco plants cured three of seven monkeys that developed symptoms from the deadly Ebola virus. The Frederick News-Post reports the treatment, called ...
Tagged with: biopharmaceutical ebola fort detrick treatment
Read More »April 19, 2013 Comments Off on Baltimore-based Cerecor obtains depression drug rights
Cerecor Inc., of Baltimore, a biopharmaceutical company focused on developing and commercializing prescription drugs involving the human nervous system, said it has acquired from Merck & Co. the exclusive, worldwide rights to a drug called MK-0657, which it said has the potential to treat depression. Merck originally developed MK-0657 for treatment of Parkinson’s disease.
Tagged with: biopharmaceutical biotechnology merck
Read More »May 7, 2012 Comments Off on Parkinson named to Zyngenia’s board of directors
David Parkinson, M.D., has been appointed to the board of directors of Zyngenia Inc., a Gaithersburg-based biopharmaceutical company, and named head of its clinical advisory board. He will also serve as interim chief medical officer. From 2007 until 2012, Parkinson ...
Tagged with: biopharmaceutical biotech food and drug administration oncology
Read More »August 5, 2011 Comments Off on MedImmune expands Frederick plant
FREDERICK — The biopharmaceutical company MedImmune is expanding its Frederick manufacturing plant. Frederick city and county officials joined the company in celebrating the official opening Friday of a 337,000-square-foot addition. The new space expands production capacity for products including Synagis, ...
Tagged with: biopharmaceutical frederick gaithersburg london maryland medimmune virus
Read More »